Delivery Order SPE2DR25D1103-SPE2DR26FE170
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,065.78 for Lacosamide 10 mg/ml solution in 200ml quantities, with an ultimate completion date of December 8, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and represents a routine pharmaceutical procurement to support federal medical supply needs. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lacosamide 10 mg/ml solution in a 200ml quantity, with a contract ceiling value of $3,155.52. This award was made on November 3, 2025, with an ultimate completion date of November 4, 2025, under a firm fixed price delivery order with no set-aside designation. The contract represents a competitive award for pharmaceutical procurement to support federal medical supply needs, with performance...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,638.72 to supply Lacosamide 10 mg/mL solution in a 200 mL quantity. This competitively awarded, firm fixed-price delivery order, issued on November 18, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX, valued at $999,999,999.00 through December 2026). The place of performance is listed as Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,565.03 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Lacosamide 10 mg/ml solution in 200 ml vials. This order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025, to deliver a comprehensive range of pharmaceuticals and medical supplies to support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Lacosamide 10 mg/ml Solution in a 200ml quantity, with a ceiling value of $2,681.84 and an ultimate completion date of August 20, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, the company's headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Lacosamide 10 mg/ml Solution in 200ml quantities, with a contract ceiling value of $1,345.12 and an ultimate completion date of December 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency Troop Support Medical awarded a $176,940 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 milliliters of the pharmaceutical product lacosamide 10 mg/ml solution. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 31, 2023 through August 1, 2023. This delivery order was issued against an existing indefinite-delivery/indefinite-quantity contract vehicle held...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 9, 2025, for the supply of Lacosamide 200 mg tablets in a quantity of 60 units. This firm fixed-price delivery order, valued at $1,539.72, represents a competitive award with no set-aside designation and is scheduled for completion by June 10, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lacosamide 100 mg/10 mL unit dose vials, a seizure and nerve pain medication, with a contract value of $3,256.98 and completion deadline of November 25, 2025. This non-set-aside, competitively awarded delivery order employs firm fixed pricing and will be performed at AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Lacosamide 10 mg/ml solution in 200ml containers. The $3,211.44 contract has a completion date of January 23, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will deliver the pharmaceutical product from its corporate office location in Conshohocken, Pennsylvania. This award is not associated with a set-aside program....
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FE170Delivery Order
The Defense Logistics Agency awarded a $2,479.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Lacosamide 10 mg/mL solution in 200 mL quantities. The contract, with an ultimate completion date of December 3, 2025, was competitively awarded without a set-aside designation. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement valued through December 2026 that enables the company to supply comprehensive pharmaceutical and medical products to support military healthcare systems globally. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capacity to deliver a wide range of pharmaceutical products across multiple therapeutic domains, from specialty medications and brand-name drugs to generic pharmaceuticals and medical supplies. The Lacosamide supply supports the Defense Health Agency and other federal healthcare customers through the flexible prime vendor contracting vehicle, which DLA is positioning as part of its Pharmaceutical Prime Vendor Global Program and planning to expand through multiple regional awards with other contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 12/1/25 |